Why Choose Private Prescription for Weight Management?
Private Prescription vs NHS Route for Wegovy and Mounjaro
The NHS pathway for accessing Wegovy and Mounjaro involves multiple barriers that can delay treatment for months. Patients must first secure a GP referral to specialist weight management services, meet strict BMI criteria with documented comorbidities, then join waiting lists averaging 6-12 months across most UK regions. Even after approval, NHS supply can be inconsistent due to procurement delays and budget constraints.
Private prescription eliminates these obstacles entirely. EverydayMeds offers both Wegovy and Mounjaro through a streamlined clinical assessment that takes just three minutes to complete online. No GP involvement is required, no waiting lists exist, and treatment can begin within 24 hours of prescriber approval. This approach particularly benefits patients who exceed NHS BMI thresholds but fall below local commissioning criteria, or those requiring immediate intervention for weight-related health concerns.
Wegovy and Mounjaro Pricing with Private Prescription
Private prescription costs for Wegovy and Mounjaro reflect their status as premium weight management treatments, but transparent pricing helps patients budget effectively. Wegovy starts at £79.99 for the 0.25mg starter dose, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose. New customers benefit from discount code FIRST40, whilst returning patients use DOSE25, both applied automatically at checkout.
Bundle options provide convenient multi-month supplies without multiple ordering cycles. The Intro Duo combining 0.25mg and 0.5mg starter doses costs £169.99, whilst the Ultimate Stability Trio provides three months of 2.4mg maintenance treatment for £649.99. These bundles ensure consistent treatment progression without supply interruptions, particularly valuable given Wegovy's mandatory dose escalation schedule requiring precise timing between strength increases.
Clinical Evidence Supporting Wegovy and Mounjaro
Both Wegovy and Mounjaro demonstrate substantial efficacy in clinical trials, though direct comparison remains impossible due to different trial designs and patient populations. The STEP programme evaluated Wegovy across multiple patient groups, with STEP 1 showing participants achieved approximately 15% average weight loss at 68 weeks when combined with lifestyle interventions, compared to 2.4% with placebo (Wilding et al., NEJM, 2021).
Mounjaro's SURMOUNT trials revealed similarly impressive outcomes, with the dual GIP/GLP-1 receptor agonist mechanism potentially offering additional metabolic benefits beyond GLP-1 stimulation alone. Both medications require prescription-only access and must be used alongside reduced-calorie diets and increased physical activity to achieve optimal results.
How Wegovy and Mounjaro Work Differently
Understanding the mechanistic differences between Wegovy and Mounjaro helps explain why prescribers might recommend one over the other for individual patients. Wegovy contains semaglutide, a selective GLP-1 receptor agonist that mimics the natural incretin hormone responsible for post-meal satiety signalling. This mechanism reduces appetite, slows gastric emptying, and enhances insulin sensitivity when blood glucose levels rise. Mounjaro contains tirzepatide, a dual GIP and GLP-1 receptor agonist that activates both incretin pathways simultaneously. This dual action potentially provides enhanced metabolic effects, though individual responses vary significantly between patients.
Streamlined Ordering Process for Wegovy and Mounjaro
EverydayMeds has refined the private prescription process to minimise delays whilst maintaining clinical safety standards. The initial assessment takes approximately three minutes, covering medical history, current medications, and weight management goals through secure online forms. Qualified prescribers review each application within three working days (or 24 hours with express service), ensuring appropriate candidate selection for either Wegovy or Mounjaro based on individual circumstances. Once approved, medications dispatch via temperature-controlled courier for next-day delivery, maintaining cold-chain integrity throughout transit to preserve medication efficacy.
Storage and Practical Considerations for Wegovy and Mounjaro
Both medications require refrigerated storage between 2-8°C before first use, but differ in room temperature stability once removed from refrigeration. Wegovy pens remain stable at room temperature below 30°C for up to six weeks, whilst Mounjaro maintains potency for 21 days under similar conditions. This storage difference may influence choice for frequent travellers or those with limited refrigeration access. Both utilise pre-filled FlexTouch injection pens designed for weekly self-administration, with dose escalation protocols that cannot be accelerated without risking gastrointestinal side effects.
Private Prescription Benefits for Wegovy and Mounjaro Access
Private prescription offers distinct advantages beyond speed of access, particularly regarding continuity of care and medication consistency. NHS patients often face treatment interruptions due to supply shortages, formulary changes, or budget restrictions that can derail weight management progress. Private patients maintain treatment continuity through direct pharmaceutical relationships, ensuring consistent supply chains and predictable monthly costs.
Additionally, private prescription allows for more personalised dosing approaches and closer monitoring arrangements. Some patients benefit from extended periods at intermediate doses before progressing, whilst others may require modified escalation schedules due to tolerability concerns. Private prescribers can accommodate these individual needs without rigid protocol adherence demanded by NHS commissioning guidelines.
Starting Your Wegovy and Mounjaro Journey Today
Beginning treatment with either Wegovy or Mounjaro through private prescription represents a significant investment in long-term health outcomes, but the pathway remains straightforward through EverydayMeds. Complete the online clinical assessment using discount codes FIRST40 (new customers) or DOSE25 (returning patients) for optimal pricing. Our GPhC-registered pharmacy (#9012878) ensures authentic medication supply with full prescriber support throughout your weight management journey. Both Wegovy and Mounjaro are available for immediate dispatch, with your chosen treatment arriving within 24 hours of prescription approval. Visit https://everydaymeds.co.uk/collections/wegovy to begin your assessment and take the first step towards sustainable weight management with professional clinical oversight.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
